Tempus AI and AstraZeneca Enter Fifth Amendment to Services Agreement
Tempus AI and AstraZeneca entered a fifth amendment to their master services agreement on Nov. 16, according to an SEC filing.
Story updates
01:32:13 PM UTC
SquawkNews
TEMPUS AI - ASTRAZENECA RETAINS RIGHT TO TERMINATE MSA FOR CONVENIENCE AT ANY TIME - SEC FILING